Showing results (141-150 of 198) with videos related to
Sort By:
Pageof 20
Atherosclerosis|April 23, 2021
Reduced adrenal stress response in patients on PCSK9 inhibitor therapySimon Meier, Marcel Frick, Michael Liu, et al.Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.Journal of the American Heart Association|April 12, 2021
Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial FibrillationAlexander P Benz, Stefanie Aeschbacher, Philipp Krisai, et al.Clinical Cardiology|November 10, 2020
Association of psychosocial factors with all-cause hospitalizations in patients with atrial fibrillationPascal B Meyre, Anne Springer, Stefanie Aeschbacher, et al.European Heart Journal|January 10, 2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardiumMartin F Reiner, Alexander Breitenstein, Erik W Holy, et al.Scientific Reports|April 15, 2025
Biomarker and cognitive decline in atrial fibrillation: a prospective cohort studyPhilipp Krisai, Magdalena Eberl, Michael Coslovsky, et al.Journal of the American Heart Association|November 10, 2021
Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss-AF StudyArjola Bano, Nicolas Rodondi, Jürg H Beer, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 23, 2023
Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial ApproachMiquel Serra-Burriel, Helena Aebersold, Fabienne Foster-Witassek, et al.Plos One|October 9, 2020
A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)Anne Springer, Andreas U Monsch, Gilles Dutilh, et al.Journal of the American Heart Association|June 1, 2023
Omega-3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial FibrillationPhilipp Baumgartner, Martin F Reiner, Andrea Wiencierz, et al.Pageof 20